TY - JOUR
T1 - Hyperdiluted calcium hydroxylapatite for skin laxity and cellulite of the skin above the knee
T2 - A pilot study
AU - Guida, Stefania
AU - Longhitano, Sabrina
AU - Shaniko, Kaleci
AU - Galadari, Hassan
AU - Chester, Johanna
AU - Ciardo, Silvana
AU - Mandel, Victor Desmond
AU - Pellacani, Giovanni
AU - Urtis, Giacomo Giovanni
AU - Farnetani, Francesca
N1 - Publisher Copyright:
© 2020 Wiley Periodicals LLC.
PY - 2020/11/1
Y1 - 2020/11/1
N2 - Despite an increasing request for skin rejuvenation above the knee, very few treatment options have been reported in literature. To evaluate the efficacy and safety of 1:4 hyperdiluted calcium hydroxylapatite (CaHA) in the treatment of skin laxity and dimples of the skin above the knees. A retrospective evaluation of hyperdiluted CaHA treatment for skin laxity and dimples above the knee was performed. Efficacy was classified as blinded evaluation of pre (T0) and 3-month post-treatment (T1) photographs by three investigators according to the validated knee cellulite severity score (KCSS) and patient satisfaction. Safety was evaluated through pain scores and adverse events evaluation. A significant reduction of KCSS at T1, as compared to T0, mainly in subjects with lower KCSS at T0, was observed (P <.05). All blinded assessments resulted in a correct identification of T0 and T1 pictures and evaluations of all investigators were found to be consistent and reliable. All patients were satisfied. Only minor adverse events (swelling, erythema, bruising, and skin irregularities) were reported, lasting 2 to 3 weeks after treatment. Our preliminary results highlight the efficacy and safety of hyperdiluted CaHA in the treatment of skin laxity and cellulite above the knees.
AB - Despite an increasing request for skin rejuvenation above the knee, very few treatment options have been reported in literature. To evaluate the efficacy and safety of 1:4 hyperdiluted calcium hydroxylapatite (CaHA) in the treatment of skin laxity and dimples of the skin above the knees. A retrospective evaluation of hyperdiluted CaHA treatment for skin laxity and dimples above the knee was performed. Efficacy was classified as blinded evaluation of pre (T0) and 3-month post-treatment (T1) photographs by three investigators according to the validated knee cellulite severity score (KCSS) and patient satisfaction. Safety was evaluated through pain scores and adverse events evaluation. A significant reduction of KCSS at T1, as compared to T0, mainly in subjects with lower KCSS at T0, was observed (P <.05). All blinded assessments resulted in a correct identification of T0 and T1 pictures and evaluations of all investigators were found to be consistent and reliable. All patients were satisfied. Only minor adverse events (swelling, erythema, bruising, and skin irregularities) were reported, lasting 2 to 3 weeks after treatment. Our preliminary results highlight the efficacy and safety of hyperdiluted CaHA in the treatment of skin laxity and cellulite above the knees.
KW - calcium hydroxylapatite
KW - cellulite
KW - hyperdiluted calcium hydroxylapatite
KW - hyperdilution
KW - knees
KW - skin laxity
UR - http://www.scopus.com/inward/record.url?scp=85089547101&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089547101&partnerID=8YFLogxK
U2 - 10.1111/dth.14076
DO - 10.1111/dth.14076
M3 - Article
C2 - 32713163
AN - SCOPUS:85089547101
SN - 1396-0296
VL - 33
JO - Dermatologic Therapy
JF - Dermatologic Therapy
IS - 6
M1 - e14076
ER -